- Home
- EXAS vs RRX Comparison
EXAS vs RRX Comparison
Compare EXAS & RRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- RRX
- Stock Information
- Founded
- EXAS 1995
- RRX 1955
- Country
- EXAS United States
- RRX United States
- Employees
- EXAS N/A
- RRX N/A
- Industry
- EXAS Medical Specialities
- RRX
- Sector
- EXAS Health Care
- RRX
- Exchange
- EXAS Nasdaq
- RRX Nasdaq
- Market Cap
- EXAS 10.7B
- RRX 9.2B
- IPO Year
- EXAS N/A
- RRX 1987
- Fundamental
- Price
- EXAS $53.02
- RRX $139.68
- Analyst Decision
- EXAS Strong Buy
- RRX Strong Buy
- Analyst Count
- EXAS 20
- RRX 9
- Target Price
- EXAS $70.68
- RRX $171.25
- AVG Volume (30 Days)
- EXAS 2.9M
- RRX 528.6K
- Earning Date
- EXAS 07-30-2025
- RRX 07-30-2025
- Dividend Yield
- EXAS N/A
- RRX 1.00%
- EPS Growth
- EXAS N/A
- RRX N/A
- EPS
- EXAS N/A
- RRX 3.50
- Revenue
- EXAS $2,828,128,000.00
- RRX $5,904,200,000.00
- Revenue This Year
- EXAS $14.58
- RRX N/A
- Revenue Next Year
- EXAS $12.75
- RRX $3.98
- P/E Ratio
- EXAS N/A
- RRX $40.02
- Revenue Growth
- EXAS 11.57
- RRX N/A
- 52 Week Low
- EXAS $39.97
- RRX $90.56
- 52 Week High
- EXAS $72.83
- RRX $185.28
- Technical
- Relative Strength Index (RSI)
- EXAS 45.95
- RRX 55.79
- Support Level
- EXAS $51.50
- RRX $138.32
- Resistance Level
- EXAS $53.30
- RRX $142.53
- Average True Range (ATR)
- EXAS 1.62
- RRX 3.53
- MACD
- EXAS -0.64
- RRX -0.82
- Stochastic Oscillator
- EXAS 26.95
- RRX 59.19
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.